GlassScriptPhysician profile
Aaron C Hager
NPI 1366749343
$1,331.61
in general payments reported to CMS, 2019-2025
13 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $34.99 · 2022: $80.42 · 2023: $522 · 2024: $314 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772 · Long Term Medical Supply Or Device Loan: $280 · Honoraria: $38.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.34 |
| Long Term Medical Supply Or Device Loan | $280.00 |
| Honoraria | $38.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $332.03 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Ocular Therapeutix, INC. | $324.32 | 2023 | Dextenza |
| Abbvie INC. | $193.74 | 2022-2024 | |
| Aerie Pharmaceuticals, INC. | $125.00 | 2019 | |
| Bausch & Lomb Americas INC. | $75.78 | 2023-2024 | Vyzulta, Xiidra, Miebo |
| Alcon Vision LLC | $75.44 | 2024-2025 | Rocklatan |
| Thea Pharma INC. | $60.95 | 2023-2024 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $49.32 | 2024-2025 | Xdemvy |
| Astellas Pharma US INC | $23.72 | 2025 | Izervay |
| Omeros Corporation | $19.24 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $18.88 | 2025 | Tecnis Iol |
| Rayner Intraocular Lenses Limited | $17.44 | 2023 | Rayone Emv, Omidria, Rayone Aspheric |
| Allergan, INC. | $15.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Hager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.